ANAB
AnaptysBioANasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
ANAB vs peer average
82/100
ANAB vs. peer average (A vs. C)
Grade spread
A 1 · B 2 · C 5 · D 2 · F 1
Graded peers loaded
Coverage
11 graded
100% of tracked
Peer overview
AMGN is the first available peer comparator.
Amgen is another broad biologics cash-flow comparator that helps anchor how the market rewards durable cash generation and shareholder returns, though it is not a direct operating match for ANAB's post-spin royalty profile.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
ANAB
AnaptysBio
AMGN
Amgen
Grade
A
C
Momentum
95
36
Value
41
64
Sentiment
53
47
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Mixed
Grade position vs AMGN
ANAB / AMGN
Grade Position
Above peers
ANAB vs. peer average (A vs. C)
82/100
Momentum
95
ANABValue
41
AMGNSentiment
53
ANABRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs ANAB
AMGN is the first peer returned for this comparison set.